|
Friends Testimony to the Federal Coordinating Council for Comparative Effectiveness Research |
 |
 |
|
Testimony by Jeff Allen, PhD, Executive Director, Friends of Cancer Research, April 14, 2009
Good afternoon. My name is Jeff Allen, Executive Director of Friends of Cancer Research. My brief remarks are based on a project we recently convened to bring 23 leading cancer researchers and advocates together in order to provide recommendations on the future of comparative effectiveness research (CER). The final report from this group will be released on May 13th.
|
|
Read more...
|
|
|
Overview of CER Provisions of the American Recovery and Reinvestment Act of 2009 |
|
|
|
On February 17, 2009, President Obama signed into law the American Recovery and Reinvestment Act of 2009, commonly referred to as the media as the Stimulus Bill.
Among its many provisions, the Act provided $1.1 billion for comparative effectiveness research (CER). This expansion of funding for CER, the largest ever federal investment in CER, carries significant potential opportunities and risks for industry, patients, and doctors.
Overview of the CER Provisions of the Act
|
|
Read more...
|
|
|
|
<< Start < Prev 1 2 3 Next > End >>
|
|
Page 3 of 3 |
